| RESEARCH ARTICLE
|Year : 2012 | Volume
| Issue : 6 | Page : 704-709
A study to evaluate the price control of antifungal medicines and its practical applicability
Amrita Sil1, Nilay Kanti Das2, Pramit Ghosh3, Pijush Kanti Datta2, Chowdhury Nazrul Islam1, Santanu Kumar Tripathi4
1 Department of Pharmacology, Burdwan Medical College, Burdwan, India
2 Department of Dermatology, Medical College, Kolkata, India
3 Department of Community Medicine, Medical College, Kolkata, India
4 Department of Experimental and Clinical Pharmacology, School of Tropical Medicine, Kolkata, India
Background: Superficial fungal infections are common and treatment imposes economic burden on the patients. Government of India had introduced price control over griseofulvin and tolnaftate in 1995; however, this measure can only benefit the needy if the policy is harmonized with the health-care service provider, that is, dermatologists. The aim of this study was to evaluate the existing Government mechanisms over price control of antifungal medications and its reach to the people-in-need.
Materials and Methods: A questionnaire-based, cross-sectional study was carried out over a period of 6 months. Questionnaire was mailed to members of a state branch of Indian Association of Dermatologists, Venereologists, and Leprologists. Responses reaching investigators within 2 months from the date of mailing were finally analyzed.
Results: Among 93 (41.33%) respondents, only 6 (6.5%) were aware of existing price control over griseofulvin but none about tolnaftate. Thirty-nine (41.9%) respondents were in favor of introducing price control on terbinafine and 42 (45.2%) for itraconazole. The topically preferred antifungals were primarily azoles and terbinafine, while among systemic antifungals, dermatologists mostly preferred fluconazole and terbinafine. The choice of antifungals by the dermatologists matched with the evidence-based dermatology data.
Conclusion: Currently, price-controlled antifungal drugs are less commonly used by practitioners. Although the dermatologists favor price control, the initiative undertaken by the Government has not reached them. This shows the need to bridge the gap between policy makers and health-care service providers to help the ailing population.
Nilay Kanti Das
Department of Dermatology, Medical College, Kolkata
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*